NO993997L - Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidol - Google Patents
Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidolInfo
- Publication number
- NO993997L NO993997L NO993997A NO993997A NO993997L NO 993997 L NO993997 L NO 993997L NO 993997 A NO993997 A NO 993997A NO 993997 A NO993997 A NO 993997A NO 993997 L NO993997 L NO 993997L
- Authority
- NO
- Norway
- Prior art keywords
- triene
- diol
- secokolesta
- calcidol
- alpha
- Prior art date
Links
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 title 1
- 229960002535 alfacalcidol Drugs 0.000 title 1
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 1
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacture Of Tobacco Products (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention concerns the use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol, for preparing a medicine for the treatment and/or prevention of solid cancer in human beings, in particular lung cancer and brain cancer. The effective dose ranges between 0.25 and 10 mu g/day for an adult weighing 60 Kg.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9702247A FR2759586B1 (en) | 1997-02-20 | 1997-02-20 | ANTI-CANCER TYPE DRUG COMPRISING AT LEAST AS THE ACTIVE INGREDIENT OF 1-ALPHA HYDROXYCALCIFEROL OR ALFACALCIDOL |
| PCT/FR1998/000347 WO1998036754A1 (en) | 1997-02-20 | 1998-02-20 | Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993997D0 NO993997D0 (en) | 1999-08-19 |
| NO993997L true NO993997L (en) | 1999-10-19 |
Family
ID=9504159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993997A NO993997L (en) | 1997-02-20 | 1999-08-19 | Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidol |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0981350B1 (en) |
| JP (1) | JP2001511818A (en) |
| KR (1) | KR20000075514A (en) |
| CN (1) | CN1248168A (en) |
| AT (1) | ATE206306T1 (en) |
| AU (1) | AU6505098A (en) |
| BR (1) | BR9807592A (en) |
| CA (1) | CA2282086A1 (en) |
| DE (1) | DE69801907D1 (en) |
| FR (1) | FR2759586B1 (en) |
| IL (1) | IL131502A0 (en) |
| NO (1) | NO993997L (en) |
| PL (1) | PL335190A1 (en) |
| TR (1) | TR199901998T2 (en) |
| WO (1) | WO1998036754A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004026811A (en) * | 2002-04-30 | 2004-01-29 | Kiyoshi Hashizume | Medicament for reinforcing anti-cancer activity, containing vitamin d3 derivative |
| GB201704909D0 (en) | 2017-03-28 | 2017-05-10 | Ldn Pharma Ltd | Cancer therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57149224A (en) * | 1981-03-13 | 1982-09-14 | Chugai Pharmaceut Co Ltd | Tumor-suppressing agent |
| IL110117A0 (en) * | 1994-06-24 | 1994-10-07 | Univ Ben Gurion | Pharmaceutical compositions comprising vitamin-d analogs |
-
1997
- 1997-02-20 FR FR9702247A patent/FR2759586B1/en not_active Expired - Fee Related
-
1998
- 1998-02-20 EP EP98910810A patent/EP0981350B1/en not_active Expired - Lifetime
- 1998-02-20 CN CN98802696A patent/CN1248168A/en active Pending
- 1998-02-20 PL PL98335190A patent/PL335190A1/en unknown
- 1998-02-20 WO PCT/FR1998/000347 patent/WO1998036754A1/en not_active Ceased
- 1998-02-20 IL IL13150298A patent/IL131502A0/en unknown
- 1998-02-20 DE DE69801907T patent/DE69801907D1/en not_active Expired - Lifetime
- 1998-02-20 TR TR1999/01998T patent/TR199901998T2/en unknown
- 1998-02-20 AT AT98910810T patent/ATE206306T1/en not_active IP Right Cessation
- 1998-02-20 KR KR1019997007573A patent/KR20000075514A/en not_active Withdrawn
- 1998-02-20 AU AU65050/98A patent/AU6505098A/en not_active Abandoned
- 1998-02-20 JP JP53634498A patent/JP2001511818A/en active Pending
- 1998-02-20 CA CA002282086A patent/CA2282086A1/en not_active Abandoned
- 1998-02-20 BR BR9807592-6A patent/BR9807592A/en not_active Application Discontinuation
-
1999
- 1999-08-19 NO NO993997A patent/NO993997L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69801907D1 (en) | 2001-11-08 |
| ATE206306T1 (en) | 2001-10-15 |
| FR2759586A1 (en) | 1998-08-21 |
| IL131502A0 (en) | 2001-01-28 |
| EP0981350B1 (en) | 2001-10-04 |
| FR2759586B1 (en) | 2000-01-14 |
| BR9807592A (en) | 2000-02-22 |
| JP2001511818A (en) | 2001-08-14 |
| EP0981350A1 (en) | 2000-03-01 |
| PL335190A1 (en) | 2000-04-10 |
| CA2282086A1 (en) | 1998-08-27 |
| WO1998036754A1 (en) | 1998-08-27 |
| AU6505098A (en) | 1998-09-09 |
| NO993997D0 (en) | 1999-08-19 |
| CN1248168A (en) | 2000-03-22 |
| TR199901998T2 (en) | 1999-11-22 |
| KR20000075514A (en) | 2000-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS553490A3 (en) | Transdermal therapeutic system | |
| FI950169L (en) | Analogues of PTH and PTHRP, their synthesis and use in the treatment of osteoporosis | |
| UA39158C2 (en) | derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon | |
| PL342078A1 (en) | Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas | |
| AP9801392A0 (en) | Concentrated antibody preparation. | |
| FI952721L (en) | Substance for the treatment of hepatobiliary diseases | |
| UA43378C2 (en) | Composition for treating the respiratory distress- syndrome of the newborns and respiratory distress- syndrome of the adult | |
| DE3070189D1 (en) | Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it | |
| WO1992012715A3 (en) | The use of loperamide and related compounds for treatment of respiratory disease symptoms | |
| ATE367808T1 (en) | N-CHLORPHENYL CARBAMATES CONTAINING MEDICINAL PRODUCT AND N-CHLORPHENYLTHIOCARBAMATES FOR INHIBITING THE GROWTH OF VIRUSES | |
| EP0676200A3 (en) | Use of eliprodil and of its enantiomers in the preparation of medicaments for the treatment of peripheral neuropathies and or central neurodegenerative diseases. | |
| NL300083I1 (en) | 1-Beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide for the preparation of a medicament for the medical treatment of humans. | |
| EP0592903A3 (en) | Use of ancrod for the preparation of drugs for the treatment of restenosis. | |
| DK0719276T3 (en) | Estradiol esters with strong oral action as well as pharmaceutical preparations containing them | |
| NO993997L (en) | Use of 9,10-secokolesta-5,7,10 (19) -triene-1-3-diol, or alpha-calcidol | |
| AU1898792A (en) | Treatment or therapeutic booth for energetic, cosmetic and medical purposes | |
| HU9402578D0 (en) | Medicament for treating or preventing cerebrovascular diseases | |
| FI961494L (en) | Pharmaceutical compositions and their use, especially for the treatment of neurodegenerative diseases | |
| FI953622A7 (en) | Use of ifenprodil and its diastereoisomers for the preparation of medicaments useful for the treatment of peripheral neuropathic conditions and degenerative diseases of the central nervous system | |
| MY114109A (en) | The use of bioassimilable boron compounds | |
| AU6819898A (en) | Oxygen anion radicals and/or therapeutic preparations containing their reaction or breakdown products, and use of such preparations in the treatment of parkinson's disease | |
| Chiyotani | Stone Flakes, Human Beings and Clinical Medicine | |
| ZA897549B (en) | Medicament for the treatment of diseases caused by retroviruses | |
| ATE74767T1 (en) | MEDICINAL COMPOSITION FOR THE TREATMENT OF LUNG OCCLUSION. | |
| IT8467837A0 (en) | 4,4'-(2-PYRIDINIL METHYLENE)BISPENOL DIACETATE AND PHARMACEUTICAL PRODUCTS INCLUDING IT FOR THE TREATMENT OF HERPES SIMPLEX |